Nitric oxide synthase inhibitor aminoguanidine potentiates iminodipropionitrile-induced neurotoxicity in rats

Neuroscience Letters

Volumn 276, Issue 1, 1999, Pages 49-52

  Tariq, Mohammad ^a   Khan, Haseeb Ahmad ^a   Al Deeb, Saleh ^a   Al Moutaery, Khalaf ^a  

^a Prince Sultan Military Medical City   (Saudi Arabia)

Author keywords

Aminoguanidine; Iminodipropionitrile; Neurotoxicity; Nitric Oxide; Vestibular toxicity

Indexed keywords

3,3' IMINODIPROPIONITRILE; AMINOGUANIDINE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CONTROLLED STUDY; DOSE RESPONSE; DYSKINESIA; HAIR CELL; HEAD MOVEMENT; HISTOPATHOLOGY; INNER EAR; MALE; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RIGHTING REFLEX;

ADMINISTRATION, ORAL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DYSKINESIA, DRUG-INDUCED; DYSKINESIAS; ENZYME INHIBITORS; GUANIDINES; HAIR CELLS; HEAD; INCIDENCE; MALE; MOVEMENT; NEUROTOXINS; NITRIC OXIDE SYNTHASE; NITRILES; RATS; RATS, WISTAR; REFLEX;

EID: 0032695822     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00789-2     Document Type: Article

References (30)

1. Abekawa T., Ohmori T., Koyama T. Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain. J. Neural. Transm. Gen. Sect. 103:1996;671-680.
2. Arenberg J.G., Komjathy D.A., Seidman M.D., Quirk W.S. Local effects of nitric oxide on vestibular blood flow in the Mongolian gerbil. Eur. Arch. Otorhinolaryngol. 253:1997;367-371.
3. Barjavel J.M., Bhargava H.N. Nitric oxide synthase activity in brain regions and spinal cord of mice and rats: kinetic analysis. Pharmacology. 50:1995;168-174.
4. Brechtelsbauer P.B., Nuttall A.L., Miller J.M. Basal nitric oxide production in regulation of cochlear blood flow. Hear. Res. 77:1994;38-40.
5. 2 antagonist - Ro22-1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile in mice. Exp. Neurol. 96:1987;594-600.
6. Chou S.M., Hartman H.A. Axonal lesions and waltzing syndrome after IDPN administration in rats. Acta Neuropathol. 3:1964;428-450.
7. Dawson T.M., Dawson V.L., Snyder S.H. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32:1992;297-311.
8. Delay J., Pichot P., Thuillier J., Marquiset J.P. Action de l'amino-dipropionitrile sur le comportement moteur de la souris blanche. C.R. Soc. Biol. 146:1952;533-534.
9. Flugel, G., Holm, S. and Flohr, H., In S. Moncada, M. Fellisch, R. Busse and E.A. Higgs (Eds.), The Biology of Nitric Oxide: Physiological and Clinical Aspects, Portland Press, London, 1994, pp. 381-387.
10. Harper A., Blythe W.R., Zdanski C.J., Prazma J., Pillsbury H.C. Nitric oxide in the rat vestibular system. Otolaryngol. Head Neck Surg. 111:1994;430-438.
11. Kitahara T., Takeda N., Emson P.C., Kubo T., Kiyama H. Change in nitric oxide synthase-like immunoreactivities in unipolar brush cells in the rat cerebellar flocculus after unilateral labyrinthectomy. Brain Res. 765:1997;1-6.
12. Llorens J., Dememes D. Hair cell degeneration resulting from 3,3′-iminodipropionitrile toxicity in the rat vestibular epithelia. Hear. Res. 76:1994;78-86.
13. Llorens J., Dememes D., Sans A. The behavioral syndrome caused by 3,3′-iminodipropionitrile and related nitriles in the rat is associated with degeneration of the vestibular sensory hair cells. Toxicol. Appl. Pharmacol. 123:1993;199-210.
14. Llorens J., Rodriguez-Farre E. Comparison of behavioral, vestibular and axonal effects of subchronic IDPN in the rat. Neurotoxicol. Teratol. 19:1992;117-127.
15. Lohr J.B., Cadet L.C., Wyatt R.J., Freed W.J. Partial reversal of the iminodipropionitrile-induced hyperkinetic syndrome in rats by α-tocopherol (vitamin E). Neuropsychopharmacology. 1:1988;305-309.
16. Moser V.C., Boyes W.K. Prolonged neurobehavioral and visual effects of short-term exposure to 3,3′-iminodipropionitrile (IDPN) in rats. Fundam. Appl. Toxicol. 21:1993;277-290.
17. Nace C.G., Genter M.B., Sayre L.M., Crofton K.M. Effect of methimazole, an FMO substrate and competitive inhibitor on the neurotoxicity of 3,3′-iminodipropionitrile in male rats. Fundam. Appl. Toxicol. 37:1997;131-140.
18. Ogawa N., Mizukawa K., Haba K., Sato H. Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile. Eur. Neurol. 30:1990;31-40.
19. Ou P., Wolff S.P. Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem. Pharmacol. 46:1993;1139-1144.
20. Rauhala P., Sziraki I., Chiueh C.C. Peroxidation of brain lipids in vitro: nitric oxide versus hydroxyl radicals. Free Rad. Biol. Med. 21:1996;391-394.
21. Schulz J.B., Matthews R.T., Muqit M.K., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
22. Selye H. Lathyrism. Rev. Can. Biol. 16:1957;1-82.
23. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters. Science. 257:1992;494-496.
24. Tariq M., Al Deeb S., Al Moutaery K., Bruyn G.W., Price Evans D., Arshaduddin M. Dipyridamole attenuates the development of iminodipropionitrile-induced dyskinetic abnormalities in rats. Brain Res. Bull. 38:1995;31-35.
25. Tariq M., Al Deeb S., Al Moutaery K., Mujeebuddin S., Arshaduddin M., Bruyn G.W. Effect of selenium and vitamin E on iminodipropionitrile-induced dyskinesia in rats. Int. J. Neurosci. 78:1995;185-192.
26. Tariq M., Khan H.A., Rehana Z., Al Moutaery K., Al Deeb S. Proglumide, a cholecystokinin receptor antagonist, exacerbates β,β′-iminodipropionitrile-induced dyskinetic syndrome in rats. Neurotoxicol. Teratol. 20:1998;571-579.
27. Wink D.A., Hanbauer I., Krishna M.C., De Graff W., Gamson J., Mitchell J.B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Nalt. Acad. Sci. USA. 90:1993;9813-9817.
28. Zdanski C.J., Prazma J., Petrusz P., Grossman G., Raymor E., Smith T.L., Pillsbury H.C. Nitric oxide synthase is an active enzyme in the spiral ganglion cells of the rat cochlea. Hear. Res. 79:1994;39-47.
29. Zhang F., Iadecola C. Nitroprusside improves blood flow and reduces brain damage after focal ischemia. NeuroReport. 4:1993;559-562.
30. Zimmerman G.A., Meistrell M., Bloom O., Cockroft K.M., Bianchi M., Risucci D., Broome J., Farmer P., Cerami A., Vlassara H. Neurotoxicity of advanced glycation end-products during focal stroke and neuroprotective effects of aminoguanidine. Proc. Natl. Acad. Sci. USA. 92:1995;3744-3748.